X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

A new era in Alzheimer’s innovation

By Andrew Powaleny  |    April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...   Read More

New report shows over 500 medicines in development for neurological disorders

By Andrew Powaleny  |    April 18, 2018
Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....   Read More

ICYMI –Report highlights increasing prevalence for Alzheimer’s disease

By Andrew Powaleny  |    December 11, 2017
The number of Americans affected by Alzheimer’s disease (AD) continues to rise according to a new report.1 Researchers found that approximately 6.08 million Americans had Alzheimer’s or mild...   Read More

Profiles in courage: Latinos in the fight against Alzheimer’s

By Guest Contributor  |    September 28, 2017
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

More than 85 medicines in development for Alzheimer’s disease

By Andrew Powaleny  |    September 21, 2017
When Brian Kursonis started “blanking out” for moments at a time, a scan revealed plaques of a protein called amyloid in the brain, one sign of Alzheimer’s disease. A test of his spinal fluid...   Read More

Medicare Monday: How finding an Alzheimer’s treatment could lower Medicare spending

By Nicole Longo  |    May 8, 2017
Alzheimer’s disease is devastating and impacts more than 5.5 million Americans and their families. While America’s biopharmaceutical researchers have been working tirelessly to find a cure for the...   Read More

Fighting disease Together: New ads feature patients and the researchers behind today’s breakthroughs

By Robert Zirkelbach  |    April 19, 2017
Today, we launched our next wave of advertising as part of the GOBOLDLY™ campaign, titled Together, featuring the stories of researchers developing cutting-edge breakthroughs alongside patients...   Read More

Continuing the search for new Alzheimer’s therapies

By Nicole Longo  |    November 10, 2016
Designated in 1983 by then-President Ronald Reagan, November marks National Alzheimer’s Disease Awareness Month – a month for all Americans to come together to raise awareness and understanding of...   Read More

Dr. George Scangos: Not just science for science’s sake

By Andrew Powaleny  |    August 10, 2016
America’s biopharmaceutical researchers are working tirelessly to develop new and innovative medicines for patients. For those diseases that have no treatment options, the opportunity to improve...   Read More

Using setbacks as stepping stones in Alzheimer’s research

By Gretta Stone  |    August 3, 2016
For decades, biopharmaceutical researchers have worked tirelessly in the pursuit of new treatments and cures for the costly and devastating Alzheimer’s disease. Advancing treatments for...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates